A detailed history of Brighton Jones LLC transactions in Glaukos Corp stock. As of the latest transaction made, Brighton Jones LLC holds 1,764 shares of GKOS stock, worth $277,142. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,764
Previous 1,765 0.06%
Holding current value
$277,142
Previous $229,000 15.28%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

SELL
$126.42 - $152.67 $126 - $152
-1 Reduced 0.06%
1,764 $264,000
Q3 2024

Oct 22, 2024

BUY
$113.62 - $135.39 $454 - $541
4 Added 0.23%
1,765 $229,000
Q2 2024

Aug 12, 2024

BUY
$89.48 - $118.35 $157,574 - $208,414
1,761 New
1,761 $208,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.48B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.